Diffuse Large B-Cell Lymphoma CNS Relapse Prophylaxis with Intrathecal or High-Dose Intravenous Methotrexate

被引:0
|
作者
Zhou, Edward [1 ]
Zheng, Kelvin [2 ]
Phyu Thin Naing [1 ]
Boisclair, Stephanie [3 ]
Goldberg, Bradley [4 ]
机构
[1] Zuckerberg Canc Ctr, New Hyde Pk, NY USA
[2] Northwell Hlth, Internal Med, Manhasset, NY USA
[3] Northwell Hlth, Zuckerberg Canc Ctr, Lake Success, NY USA
[4] Zuckerberg Canc Ctr, Lake Success, NY USA
关键词
D O I
10.1182/blood-2023-172831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma
    Pillar, Nir
    Bairey, Osnat
    Goldschmidt, Neta
    Fellig, Yakov
    Rosenblat, Yevgenia
    Shehtman, Itchak
    Haguel, Danielle
    Raanani, Pia
    Shomron, Noam
    Siegal, Tali
    ONCOTARGET, 2017, 8 (49) : 86020 - 86030
  • [42] MicroRNAs AS PREDICTORS FOR CNS RELAPSE OF SYSTEMIC DIFFUSE LARGE B-CELL LYMPHOMA
    Pillar, Nir
    Bairey, Osnat
    Goldschmidt, Neta
    Fellig, Yakov
    Rosenblat, Yevgenia
    Shehtman, Itchak
    Haguel, Danielle
    Raanani, Pia
    Siegal, Tali
    NEURO-ONCOLOGY, 2017, 19 : 172 - 172
  • [43] Reply to Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma
    Abramson, Jeremy S.
    Hochberg, Ephraim P.
    CANCER, 2011, 117 (11) : 2580 - 2581
  • [44] CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?
    Siegal, Tali
    Goldschmidt, Neta
    BLOOD REVIEWS, 2012, 26 (03) : 97 - 106
  • [45] Experience with high-dose chemotherapy in patients with testicular diffuse large B-cell lymphoma
    Nesterova, E. S.
    Mangasarova, Ya. K.
    Baryakh, E. A.
    Gubkin, A. V.
    Tolstykh, T. N.
    Lukina, A. I.
    Kovrigina, A. M.
    Domracheva, E. V.
    Chernova, N. G.
    Maryin, D. S.
    Zvonkov, E. E.
    Gemdjian, E. G.
    Kravchenko, S. K.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (07) : 59 - 67
  • [46] High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma
    Chamberlain, Marc C.
    Johnston, Sandra K.
    NEURO-ONCOLOGY, 2010, 12 (07) : 736 - 744
  • [47] Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse
    Akimoto, Masahiro
    Miyazaki, Takuya
    Takahashi, Hiroyuki
    Saigusa, Yusuke
    Takeda, Takaaki
    Hibino, Yuto
    Tokunaga, Mayumi
    Ohashi, Takuma
    Matsumura, Ayako
    Teshigawara, Haruka
    Suzuki, Taisei
    Teranaka, Hiroshi
    Nakajima, Yuki
    Matsumoto, Kenji
    Hashimoto, Chizuko
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Sakai, Rika
    Fujisawa, Shin
    Nakajima, Hideaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (02) : 164 - 172
  • [48] Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse
    Masahiro Akimoto
    Takuya Miyazaki
    Hiroyuki Takahashi
    Yusuke Saigusa
    Takaaki Takeda
    Yuto Hibino
    Mayumi Tokunaga
    Takuma Ohashi
    Ayako Matsumura
    Haruka Teshigawara
    Taisei Suzuki
    Hiroshi Teranaka
    Yuki Nakajima
    Kenji Matsumoto
    Chizuko Hashimoto
    Katsumichi Fujimaki
    Hiroyuki Fujita
    Rika Sakai
    Shin Fujisawa
    Hideaki Nakajima
    International Journal of Hematology, 2024, 119 (2) : 164 - 172
  • [50] Low Rate of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Despite Limited Use of Intrathecal Prophylaxis
    Aleem, Aamer
    Algahtani, Farjah
    Alzahrani, Musa
    Jamal, Ahmed
    Alsaleh, Khalid
    Sewaralthahab, Sarah
    Alshalati, Fatimah
    Aloraini, Omar
    Almozini, Mohammed
    Abdulkarim, Abdulaziz
    Alayed, Omar
    Alotaibi, Ghazi
    JOURNAL OF HEMATOLOGY, 2025, 14 (01) : 14 - 19